Thursday, August 9, 2018

“The FDA is inspecting compounding facilities to assess whether drugs that are essentially copies of FDA-approved drugs are being compounded for patients” who could otherwise take a product sold commercially, he said in a statement issued on June 28."

quoted from 
Pharmacy-Made Pain Creams Flagged On Fears Of Medicare Fraud And Risk
Washington Post · 
Post a Comment